A phase Ib trial of daratumumab in combination with atezolizumab in solid tumour
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2016
At a glance
- Drugs Atezolizumab (Primary) ; Daratumumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 23 Mar 2016 New trial record
- 21 Mar 2016 According to a Genmab media release, this and other trial (see profile 256576) anticipated to start dosing patients within a year.
- 21 Mar 2016 According to a Genmab media release, this trial will be sponsored by Janssen.